190 related articles for article (PubMed ID: 23845188)
21. Substance P enhances mesenchymal stem cells-mediated immune modulation.
Jin Y; Hong HS; Son Y
Cytokine; 2015 Feb; 71(2):145-53. PubMed ID: 25461392
[TBL] [Abstract][Full Text] [Related]
22. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15.
Bocelli-Tyndall C; Bracci L; Schaeren S; Feder-Mengus C; Barbero A; Tyndall A; Spagnoli GC
Ann Rheum Dis; 2009 Aug; 68(8):1352-9. PubMed ID: 18647856
[TBL] [Abstract][Full Text] [Related]
23. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
[TBL] [Abstract][Full Text] [Related]
24. CD8 T cell of donor splenocyte mixed with bone marrow cells is more effective than CD4 T cell for induction of donor-specific tolerance in sublethally irradiated mice.
Yoshida A; Narumi S; Hashimoto N; Itabashi Y; Hakamada K; Sasaki M
Transplant Proc; 2004 Oct; 36(8):2418-22. PubMed ID: 15561266
[TBL] [Abstract][Full Text] [Related]
25. Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.
Yang AS; Lattime EC
Cancer Res; 2003 May; 63(9):2150-7. PubMed ID: 12727833
[TBL] [Abstract][Full Text] [Related]
26. Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells.
Poggi A; Zocchi MR
Hum Immunol; 2008 Nov; 69(11):755-9. PubMed ID: 18817823
[TBL] [Abstract][Full Text] [Related]
27. In vitro testing of immunosupressive effects of mesenchymal stromal cells on lymphocytes stimulated with alloantigens.
Lysak D; Vlas T; Holubova M; Miklikova M; Jindra P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):215-9. PubMed ID: 24077235
[TBL] [Abstract][Full Text] [Related]
28. Activated allogeneic NK cells as suppressors of alloreactive responses.
Hu B; He Y; Wu Y; Bao G; Liu H; Welniak LA; Murphy WJ
Biol Blood Marrow Transplant; 2010 Jun; 16(6):772-81. PubMed ID: 20197103
[TBL] [Abstract][Full Text] [Related]
29. Mesenchymal stem cells together with mycophenolate mofetil inhibit antigen presenting cell and T cell infiltration into allogeneic heart grafts.
Eggenhofer E; Steinmann JF; Renner P; Slowik P; Piso P; Geissler EK; Schlitt HJ; Dahlke MH; Popp FC
Transpl Immunol; 2011 Apr; 24(3):157-63. PubMed ID: 21194567
[TBL] [Abstract][Full Text] [Related]
30. [Effects of mesenchymal stem cells on lymphocyte proliferation of sensitized mice in vitro and their action manner].
Hong DL; Wu YF; Xu LH; Fang JP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1209-13. PubMed ID: 22040973
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stromal cells derived from CD271(+) bone marrow mononuclear cells exert potent allosuppressive properties.
Kuçi Z; Kuçi S; Zircher S; Koller S; Schubert R; Bönig H; Henschler R; Lieberz R; Klingebiel T; Bader P
Cytotherapy; 2011 Nov; 13(10):1193-204. PubMed ID: 21905954
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
[TBL] [Abstract][Full Text] [Related]
33. Differential immunomodulatory effects of fetal versus maternal multipotent stromal cells.
Roelen DL; van der Mast BJ; in't Anker PS; Kleijburg C; Eikmans M; van Beelen E; de Groot-Swings GM; Fibbe WE; Kanhai HH; Scherjon SA; Claas FH
Hum Immunol; 2009 Jan; 70(1):16-23. PubMed ID: 19010366
[TBL] [Abstract][Full Text] [Related]
34. Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells.
Samuelsson H; Ringdén O; Lönnies H; Le Blanc K
Cytotherapy; 2009; 11(2):129-36. PubMed ID: 19152151
[TBL] [Abstract][Full Text] [Related]
35. Immunomodulatory properties of FK734, a humanized anti-CD28 monoclonal antibody with agonistic and antagonistic activities.
Shiao SL; McNiff JM; Masunaga T; Tamura K; Kubo K; Pober JS
Transplantation; 2007 Feb; 83(3):304-13. PubMed ID: 17297405
[TBL] [Abstract][Full Text] [Related]
36. Marked induction of CD4+CD8+ T cells with multifunctional properties by coculturing CD2+ cells with xenogeneic stromal cells.
Otani T; Toraya T; Sugimoto A; Okochi A; Suzuki M; Takeuchi M; Yamasaki F; Nakamura S; Kibata M
J Immunol Methods; 2011 Sep; 372(1-2):78-88. PubMed ID: 21767541
[TBL] [Abstract][Full Text] [Related]
37. Intravenous administration of bone marrow mesenchymal stem cells benefits experimental autoimmune myasthenia gravis mice through an immunomodulatory action.
Yu J; Zheng C; Ren X; Li J; Liu M; Zhang L; Liang L; Du W; Han ZC
Scand J Immunol; 2010 Sep; 72(3):242-9. PubMed ID: 20696022
[TBL] [Abstract][Full Text] [Related]
38. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells.
English K; Barry FP; Field-Corbett CP; Mahon BP
Immunol Lett; 2007 Jun; 110(2):91-100. PubMed ID: 17507101
[TBL] [Abstract][Full Text] [Related]
39. Co-culture of spleen stromal cells with bone marrow mononuclear cells leads to the generation of a novel macrophage subset.
Wang X; Li Y; Xiao H; Zhang X; Cao J; Zhang D; Zhang J; Li X; Shen B; Wang Q; Shi Y
Scand J Immunol; 2014 Jan; 79(1):27-36. PubMed ID: 24313872
[TBL] [Abstract][Full Text] [Related]
40. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
